<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE article
  PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:xlink="http://www.w3.org/1999/xlink" article-type="research-article" xml:lang="en">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">JBA</journal-id>
<journal-id journal-id-type="hwp">spjba</journal-id>
<journal-id journal-id-type="nlm-ta">J Biomater Appl</journal-id>
<journal-title>Journal of Biomaterials Applications</journal-title>
<issn pub-type="ppub">0885-3282</issn>
<issn pub-type="epub">1530-8022</issn>
<publisher>
<publisher-name>SAGE Publications</publisher-name>
<publisher-loc>Sage UK: London, England</publisher-loc>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.1177/0885328212440600</article-id>
<article-id pub-id-type="publisher-id">10.1177_0885328212440600</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Articles</subject>
</subj-group>
</article-categories>
<title-group>
<article-title>Differences in proliferation, differentiation, and cytokine production by bone cells seeded on titanium–nitride and cobalt–chromium–molybdenum surfaces</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>van Hove</surname><given-names>Ruud P</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212440600">1</xref>
<xref ref-type="aff" rid="aff2-0885328212440600">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Nolte</surname><given-names>Peter A</given-names></name>
<xref ref-type="aff" rid="aff2-0885328212440600">2</xref>
</contrib>
<contrib contrib-type="author">
<name><surname>Semeins</surname><given-names>Cornelis M</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212440600">1</xref>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Klein-Nulend</surname><given-names>Jenneke</given-names></name>
<xref ref-type="aff" rid="aff1-0885328212440600">1</xref>
<xref ref-type="corresp" rid="corresp1-0885328212440600"/>
</contrib>
</contrib-group>
<aff id="aff1-0885328212440600"><label>1</label>Department of Oral Cell Biology, Research Institute MOVE, ACTA-University of Amsterdam and VU University Amsterdam, The Netherlands</aff>
<aff id="aff2-0885328212440600"><label>2</label>Department of Orthopedics, Spaarne Hospital, The Netherlands</aff>
<author-notes>
<corresp id="corresp1-0885328212440600">Jenneke Klein-Nulend, Department of Oral Cell Biology, Research Institute MOVE, ACTA-University of Amsterdam and VU University Amsterdam, Gustav Mahlerlaan 3004, 1081 LA Amsterdam, The Netherlands. Email: <email>j.kleinnulend@acta.nl</email></corresp>
</author-notes>
<pub-date pub-type="epub-ppub">
<month>8</month>
<year>2013</year>
</pub-date>
<volume>28</volume>
<issue>2</issue>
<fpage>278</fpage>
<lpage>287</lpage>
<permissions>
<copyright-statement>© The Author(s) 2012 Reprints and permissions: sagepub.co.uk/journalsPermissions.nav</copyright-statement>
<copyright-year>2012</copyright-year>
<copyright-holder content-type="sage">SAGE Publications</copyright-holder>
</permissions>
<abstract>
<p>Titanium–nitride coating is used to improve cobalt–chromium–molybdenum implant survival in total knee arthroplasty, but its effect on osteoconduction is unknown. Chromium and cobalt ions negatively affect the growth and metabolism of cultured osteoblasts while enhancing osteoclastogenic cytokine production. Therefore, it was hypothesized that a titanium–nitride surface would enhance osteoblast proliferation and/or differentiation and reduce osteoclastogenic cytokine production compared with a cobalt–chromium–molybdenum surface. MC3T3-E1 osteoblasts showed increased proliferation and decreased differentiation on titanium–nitride, while cytokine interleukin-6 production was higher on porous cobalt–chromium–molybdenum (<italic>p</italic> &lt; 0.05), though interleukin-1β was occasionally detected on both surfaces. These findings suggest improved osteoconduction on titanium–nitride compared with cobalt–chromium–molybdenum surface.</p>
</abstract>
<kwd-group>
<kwd>MC3T3-E1 osteoblasts</kwd>
<kwd>titanium–nitride</kwd>
<kwd>cobalt–chromium–molybdenum</kwd>
<kwd>proliferation</kwd>
<kwd>differentiation</kwd>
<kwd>cytokine production</kwd>
</kwd-group>
</article-meta>
</front>
<body>
<sec id="sec1-0885328212440600" sec-type="intro"><title>Introduction</title>
<p>Osteoarthritis of the knee is a common cause of pain and disability. In severe cases, total knee arthroplasty is recommended to relieve pain and disability with high rate of success.<sup><xref ref-type="bibr" rid="bibr1-0885328212440600">1</xref>,<xref ref-type="bibr" rid="bibr2-0885328212440600">2</xref></sup> However, failure of such surgery may result in postoperative pain, poor function, and occasionally revision surgery.<sup><xref ref-type="bibr" rid="bibr3-0885328212440600">3</xref><xref ref-type="bibr" rid="bibr4-0885328212440600"/>–<xref ref-type="bibr" rid="bibr5-0885328212440600">5</xref></sup> The mechanisms underlying failure include wear of the polyethylene insert, aseptic loosening, instability, and infection.<sup><xref ref-type="bibr" rid="bibr3-0885328212440600">3</xref>,<xref ref-type="bibr" rid="bibr5-0885328212440600">5</xref></sup> Early failure, i.e. revision surgery within 2 years, is mainly due to infection, instability, and loosening.<sup><xref ref-type="bibr" rid="bibr5-0885328212440600">5</xref></sup> Early loosening has been shown to be associated with uncemented rather than cemented total knee arthroplasty.<sup><xref ref-type="bibr" rid="bibr4-0885328212440600">4</xref>,<xref ref-type="bibr" rid="bibr5-0885328212440600">5</xref></sup></p>
<p>In total knee arthroplasty, the femoral and tibial prosthesis’ components can be fixated by polymethyl-methacrylate (PMMA or cement) between bone and the components (cemented total knee arthroplasty) or by bone ingrowth into the porous surface of the components (uncemented total knee arthroplasty). Bone ingrowth starts with osteoconduction, i.e. bone growth on a surface, leading to osseointegration, and direct anchorage of the implant.<sup><xref ref-type="bibr" rid="bibr6-0885328212440600">6</xref></sup> Long-term durability of cemented total knee arthroplasty is questionable due to signs of osteolytic activity at the cement–bone interface.<sup><xref ref-type="bibr" rid="bibr7-0885328212440600">7</xref></sup> Uncemented total knee arthroplasty was designed to improve the longevity of implants in younger patients with osteoarthritis.<sup><xref ref-type="bibr" rid="bibr8-0885328212440600">8</xref></sup> However, the rate of aseptic loosening in uncemented total knee arthroplasty with need for revision is higher than that in cemented total knee arthroplasty.<sup><xref ref-type="bibr" rid="bibr1-0885328212440600">1</xref>,<xref ref-type="bibr" rid="bibr4-0885328212440600">4</xref></sup></p>
<p>Cobalt, chromium, and molybdenum (CoCrMo) alloy exhibits high wear resistance and is therefore used to manufacture the tibial and femoral components of total knee prostheses.<sup><xref ref-type="bibr" rid="bibr9-0885328212440600">9</xref>,<xref ref-type="bibr" rid="bibr10-0885328212440600">10</xref></sup> Some implants have a titanium–nitride (TiN) coating of 3–4 µm applied by physical vapor deposition.<sup><xref ref-type="bibr" rid="bibr10-0885328212440600">10</xref></sup> TiN provides the CoCrMo surface with increased hardness, a low coefficient of friction, and higher resistance to adhesive wear compared with CoCrMo, which are favorable characteristics for long-term survival of the implant, since it prevents the potentially harmful effects of accumulation of chromium and cobalt ions in the body.<sup><xref ref-type="bibr" rid="bibr10-0885328212440600">10</xref>,<xref ref-type="bibr" rid="bibr11-0885328212440600">11</xref></sup> Chromium and cobalt ions negatively affect growth and metabolism of osteoblastic cells <italic>in vitro</italic>.<sup><xref ref-type="bibr" rid="bibr12-0885328212440600">12</xref>,<xref ref-type="bibr" rid="bibr13-0885328212440600">13</xref></sup> These ions also enhance the release of interleukin-1β (IL-1β) and tumor necrosis factor-α (TNF-α).<sup><xref ref-type="bibr" rid="bibr14-0885328212440600">14</xref></sup> Cobalt ions alone enhance the release of interleukin-6 (IL-6) by human osteoblasts <italic>in vitro</italic>.<sup><xref ref-type="bibr" rid="bibr14-0885328212440600">14</xref></sup></p>
<p>Osteoblast-like cells produce the cytokines interleukin-1 (IL-1), IL-6, and TNF-α.<sup><xref ref-type="bibr" rid="bibr15-0885328212440600">15</xref><xref ref-type="bibr" rid="bibr16-0885328212440600"/><xref ref-type="bibr" rid="bibr17-0885328212440600"/><xref ref-type="bibr" rid="bibr18-0885328212440600"/>–<xref ref-type="bibr" rid="bibr19-0885328212440600">19</xref></sup> In bone remodeling, cytokines IL-1, IL-6, and TNF-α regulate osteoclastogenesis.<sup><xref ref-type="bibr" rid="bibr20-0885328212440600">20</xref></sup> They stimulate osteoclast differentiation in a synergistic fashion with a net increase in receptor activator of nuclear factor kappa B ligand (RANKL) activity.<sup><xref ref-type="bibr" rid="bibr20-0885328212440600">20</xref>,<xref ref-type="bibr" rid="bibr21-0885328212440600">21</xref></sup> Binding of RANKL to RANK stimulates differentiation of osteoclast precursors into mature osteoclasts and activation of osteoclastic bone resorption.<sup><xref ref-type="bibr" rid="bibr20-0885328212440600">20</xref></sup> Moreover, IL-1, IL-6, and TNF-α cytokines induce osteoclast differentiation in an <italic>in vitro</italic> mouse model for aseptic loosening.<sup><xref ref-type="bibr" rid="bibr22-0885328212440600">22</xref></sup></p>
<p>The aim of this study was to test whether differences exist in MC3T3-E1 osteoblast proliferation, differentiation, and/or cytokine production when these cells are cultured on TiN surface compared with CoCrMo surface. We hypothesized that both smooth and porous TiN surface would enhance MC3T3-E1 osteoblast proliferation and/or differentiation and diminish the production of cytokines by these cells compared with CoCrMo surface. This could enhance osteoconduction and osseointegration, which might lead to a lower rate of early aseptic loosening of the implant <italic>in vivo</italic>.</p>
</sec>
<sec id="sec2-0885328212440600" sec-type="materials|methods"><title>Materials and methods</title>
<sec id="sec3-0885328212440600" sec-type="materials"><title>Materials</title>
<p>Hundred and ninety-two discs composed of CoCrMo alloy (diameter 25.5 mm, height 3.3 mm) were tested. Ninety-six discs were composed of CoCrMo alloy, of which 48 discs were uncoated (smooth CoCrMo discs) and 48 discs were coated with spherical CoCrMo beads (porous CoCrMo discs) as used at the bone–implant interface of total knee arthroplasty for bone ingrowth (Porocoat®, DePuy-Johnson and Johnson, Warsaw, IN) (<xref ref-type="table" rid="table1-0885328212440600">Table 1</xref>). Ninety-six other discs composed of CoCrMo alloy (48 uncoated discs (smooth TiN discs) and 48 discs with a spherical beads coating (porous TiN discs)) were coated with a thin TiN layer (∼4 µm thickness) applied by physical vapor deposition (Implantcast GmbH, Buxtehude, Germany) (<xref ref-type="table" rid="table1-0885328212440600">Table 1</xref>). Polystyrene tissue culture plates (Cellstar®, Greiner Bio-One GmbH, Frickenhausen, Germany) were used as reference for MC3T3-E1 osteoblast cultures. Prior to utilization, all discs were ultrasonically cleaned in soapy water, 70% ethanol, and de-ionized water. The discs were packed in sterilization pouches, autoclaved (Prestige Medical, Blackburn, UK) for 22 min at 121℃, and allowed to dry overnight at 60℃. The discs tested were scanned using a scanning electron microscope (SEM, Philips XL20, Philips Electronics NV, Eindhoven, the Netherlands). SEM was used to identify possible surface differences in samples of the tested materials.
<table-wrap id="table1-0885328212440600" position="float"><label>Table 1.</label><caption><p>Experimental design of this study indicating the number of porous and smooth CoCrMo and TiN discs used in this study for DNA, ALP, IL-1β, IL-6, and TNF-α analysis after 1, 2, 4, or 7 days of MC3T3-E1 osteoblast culture.</p></caption>
<graphic alternate-form-of="table1-0885328212440600" xlink:href="10.1177_0885328212440600-table1.tif"/>
<table frame="hsides"><thead align="left">
<tr><th colspan="16">Total number of discs (192)</th>
</tr>
<tr><th colspan="4">Smooth CoCrMo discs (48)</th>
<th colspan="4">Porous CoCrMo discs (48)</th>
<th colspan="4">Smooth TiN discs (48)</th>
<th colspan="4">Porous TiN discs (48)</th>
</tr>
<tr><th colspan="4">Day</th>
<th colspan="4">Day</th>
<th colspan="4">Day</th>
<th colspan="4">Day</th>
</tr></thead>
<tbody align="left">
<tr>
<td>1 (12)</td>
<td>2 (12)</td>
<td>4 (12)</td>
<td>7 (12)</td>
<td>1 (12)</td>
<td>2 (12)</td>
<td>4 (12)</td>
<td>7 (12)</td>
<td>1 (12)</td>
<td>2 (12)</td>
<td>4 (12)</td>
<td>7 (12)</td>
<td>1 (12)</td>
<td>2 (12)</td>
<td>4 (12)</td>
<td>7 (12)</td>
</tr>
<tr>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
<td>DNA (4)</td>
</tr>
<tr>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
<td>ALP (4)</td>
</tr>
<tr>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
<td>IL-1β (4)</td>
</tr>
<tr>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
<td>IL-6 (4)</td>
</tr>
<tr>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
<td>TNF-α (4)</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn1-0885328212440600">
<p>CoCrMo: cobalt–chromium–molybdenum; TiN: titanium–nitride; DNA: DNA of MC3T3-E1 osteoblasts cultured on discs; ALP: alkaline phosphatase activity of MC3T3-E1 osteoblasts cultured on discs; IL-1β: interleukin-1β in culture medium of MC3T3-E1 osteoblasts cultured on discs; IL-6: interleukin-6 in culture medium of MC3T3-E1 osteoblasts cultured on discs; and TNF-α: tumor necrosis factor-α in culture medium of MC3T3-E1 osteoblasts cultured on discs.</p></fn>
<fn id="table-fn2-0885328212440600">
<p>Number of discs are given in parentheses.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec4-0885328212440600"><title>Bone cell culture</title>
<p>MC3T3-E1 osteoblasts were cultured in α-minimum essential medium (α-MEM, Gibco, Paisley, UK) supplemented with 10 mM ß-glycerophosphate (Sigma–Aldrich, St. Louis, MO, USA), 300 µg/mL <sc>l</sc>-glutamine (Sigma–Aldrich), 50 µg/mL ascorbic acid (Merck, Darmstadt, Germany), 100 U/mL penicillin (Sigma–Aldrich), 50 mg/mL streptomycin (Sigma–Aldrich), 1.25 µg/mL fungizone (Gibco), and 10% fetal bovine serum (Hyclone, Logan, UT) in a CO<sub>2</sub> incubator (Hera Cell, Heraeus, Hanau, Germany) at 37℃ in a 99% humidity atmosphere and 5% CO<sub>2</sub> in air. After reaching 90–100% confluency, MC3T3-E1 osteoblasts were trypsinized with 0.25% trypsin (Difco Laboratories, Detroit, MI, USA) and 0.1% EDTA (Sigma–Aldrich) in phosphate-buffered saline (PBS) as described before.<sup><xref ref-type="bibr" rid="bibr23-0885328212440600">23</xref></sup></p>
<p>MC3T3-E1 osteoblasts at passage 16 were seeded at 1 × 10<sup>5</sup> cells/disc in 0.5 mL culture medium consisting of α-MEM (Gibco) with 10 mM ß-glycerophosphate (Sigma–Aldrich), 300 µg/mL <sc>l</sc>-glutamine (Sigma–Aldrich), 50 µg/mL ascorbic acid (Merck), 100 U/mL penicillin (Sigma–Aldrich), 50 mg/mL streptomycin (Sigma–Aldrich), 1.25 µg/mL fungizone (Gibco), and 10% fetal bovine serum (Hyclone) to study cell proliferation, differentiation, and cytokine production. MC3T3-E1 osteoblasts were placed on top of the discs to allow cell adhesion to the discs for 45 min in a CO<sub>2</sub> incubator (Hera Cell) at 37℃ in a 99% humidity atmosphere and 5% CO<sub>2</sub> in air, at which time an additional 4.5 mL culture medium/well was added. Control cultures without discs were cultured in 2.5 mL of culture medium to reach the same height of medium on the MC3T3-E1 osteoblasts during culture on discs. After 1, 2, 4, and 7 days of culture at 37℃ and 5% CO<sub>2</sub> in air at 99% humidity, medium was collected to measure IL-1β, IL-6, and TNF-α by enzyme-linked immunosorbent assay (ELISA).</p>
<p><xref ref-type="table" rid="table1-0885328212440600">Table 1</xref> shows the experimental design of this study indicating the number of porous and smooth CoCrMo and TiN discs used in this study for DNA, alkaline phosphatase (ALP), IL-1β, IL-6, and TNF-α analysis after 1, 2, 4, or 7 days of MC3T3-E1 osteoblast culture. The cell-containing discs and control cell cultures on polystyrene were rinsed with PBS, and adhered cells were lysed with 0.5 mL 0.05% Triton® X-100 and stored at −80℃ until further analysis. The porous-coated discs were put in 50 mL polyethylene canisters (Greiner Bio-One) and centrifuged at 600 relative centrifugal force for 1 min to collect the total amount of cell lysate.</p>
<p>On days 1, 2, 4, and 7, a disc of each material with MC3T3-E1 osteoblasts was used for SEM. After rinsing with PBS, MC3T3-E1 osteoblasts were fixed with 4% paraformaldehyde (Merck), 1% glutaraldehyde (Merck), and 0.1 M sodium cacodylate (SERVA Electrophoresis GmbH, Heidelberg, Germany) in PBS for 30 min. MC3T3-E1 osteoblasts were rinsed with PBS, dehydrated in 70%, 80%, 90%, and 96% alcohol and air-dried. Discs were sputtered with gold using a sputter coater (Edwards S150B, Crawley, UK) to visualize cells by SEM.</p>
</sec>
<sec id="sec5-0885328212440600"><title>Proliferation</title>
<p>Adhered MC3T3-E1 osteoblasts were lysed using a cell lysis buffer as described under bone cell culture. Cell lysate was processed according to the protocol of the CyQuant cell proliferation assay (Molecular Probes, Carlsbad, CA). The cell proliferation assay measures DNA concentration, which is proportionally related to cell number. Fluorescence intensity was measured using a fluorescence microplate reader (Wallac 1420 Victor 2, Perkin Elmer, Boston, MA, USA) with excitation at 485 nm and emission detection at 530 nm. A standard curve for fluorescence intensity versus DNA concentration in ng/mL was generated.</p>
</sec>
<sec id="sec6-0885328212440600"><title>Differentiation</title>
<p>ALP activity was measured in the cell lysate using <italic>p</italic>-nitrophenylphosphate (Merck) as a substrate at pH 10.3, according to the method described by Bessey et al.<sup><xref ref-type="bibr" rid="bibr24-0885328212440600">24</xref></sup> Plates were read at 405 nm. ALP activity was expressed as nmol <italic>p</italic>-nitrophenylphosphate/µg protein. Total cellular protein content was measured with a bicinchoninic acid protein assay (Pierce, Rockford, IL). Plates were read at 540–590 nm.</p>
</sec>
<sec id="sec7-0885328212440600"><title>Cytokine production</title>
<p>Cytokines IL-1β, IL-6, and TNF-α were quantitatively determined in culture medium using ELISA (Quantikine, R&amp;D Systems, Minneapolis, MN, USA). Cytokine concentrations were measured according to the manufacturers’ instructions. The minimum detectable dose was 3.0 pg/mL for IL-1β, 1.6 pg/mL for IL-6, and 5.1 pg/mL for TNF-α.</p>
</sec>
<sec id="sec8-0885328212440600"><title>Statistical analysis</title>
<p>Statistical analysis was performed using Kyplot (KyensLab Inc., Tokyo, Japan). Data obtained from separate experiments were pooled and expressed as mean ± standard error of the mean. Data were analyzed using a paired <italic>t</italic>-test. Differences were considered statistically significant if <italic>p</italic> &lt; 0.050.</p>
</sec>
</sec>
<sec id="sec9-0885328212440600" sec-type="results"><title>Results</title>
<sec id="sec10-0885328212440600"><title>Scanning electron microscopy</title>
<p>SEM analysis of CoCrMo discs showed a smooth surface with a spherical pattern due to polishing of irregularities (<xref ref-type="fig" rid="fig1-0885328212440600">Figure 1(A)</xref>). TiN discs showed a smooth surface with circular tracks due to the production process (<xref ref-type="fig" rid="fig1-0885328212440600">Figure 1(B)</xref>). Porous-coated CoCrMo discs showed a multilayered surface of smooth, reflectant beads with a diameter of ∼200–250 µm (<xref ref-type="fig" rid="fig1-0885328212440600">Figure 1(C)</xref>). Porous-coated TiN discs showed a multilayered surface of beads with a diameter of ∼300 µm, which were less smooth and reflectant indicating the presence of TiN coating (<xref ref-type="fig" rid="fig1-0885328212440600">Figure 1(D)</xref>).
<fig id="fig1-0885328212440600" position="float"><label>Figure 1.</label><caption><p>SEM images of discs with (A) CoCrMo surface, (B) TiN surface, (C) porous-coated CoCrMo surface, and (D) porous-coated TiN surface. Scale bar, 200 µm. Magnification, ×100. SEM: scanning electron microscope; CoCrMo: cobalt–chromium–molybdenum; and TiN: titanium–nitride.</p></caption><graphic xlink:href="10.1177_0885328212440600-fig1.tif"/>
</fig></p>
<p>On day 1 of culture, MC3T3-E1 osteoblasts were present in similar density and orientation on both smooth CoCrMo and TiN surfaces. On day 2, MC3T3-E1 osteoblasts were present in a low density and were connected to each other with dendrites on smooth CoCrMo (<xref ref-type="fig" rid="fig2-0885328212440600">Figure 2(A)</xref>). On day 4, osteoblast density on smooth CoCrMo seemed to increase (<xref ref-type="fig" rid="fig2-0885328212440600">Figure 2(C)</xref>). On day 2 of culture on smooth TiN, MC3T3-E1 osteoblasts aligned with the circular surface pattern (<xref ref-type="fig" rid="fig2-0885328212440600">Figure 2(B)</xref>). On day 4, osteoblasts on smooth TiN showed similar density and alignment as on day 2 (<xref ref-type="fig" rid="fig2-0885328212440600">Figure 2(D)</xref>). On day 7, osteoblasts on smooth TiN showed increased density with similar alignment compared with day 4. Unfortunately, cells were lost on smooth CoCrMo on day 7 and on porous surfaces at each time point.
<fig id="fig2-0885328212440600" position="float"><label>Figure 2.</label><caption><p>SEM images of MC3T3-E1 osteoblasts on CoCrMo and TiN after 2 and 4 days of culture. Osteoblasts on (A) CoCrMo, day 2; (B) TiN, day 2; (C) CoCrMo, day 4; and (D) TiN, day 4. Scale bar, 100 µm. Magnification, ×250. SEM: scanning electron microscope; CoCrMo: cobalt–chromium–molybdenum; and TiN: titanium–nitride.</p></caption><graphic xlink:href="10.1177_0885328212440600-fig2.tif"/>
</fig></p>
</sec>
<sec id="sec11-0885328212440600"><title>Proliferation</title>
<p>Proliferation of MC3T3-E1 osteoblasts on porous CoCrMo increased from day 1 to 4 (<italic>p</italic> = 0.01), but decreased from day 4 to 7 (<italic>p</italic> = 0.03). Increased proliferation was seen on porous TiN from day 1 to 7 (<italic>p</italic> = 0.003). Proliferation on porous TiN was higher than that on porous CoCrMo on day 2 (<italic>p</italic> &lt; 0.01) and day 7 (<italic>p</italic> &lt; 0.01) (<xref ref-type="fig" rid="fig3-0885328212440600">Figure 3(A)</xref>, <xref ref-type="table" rid="table2-0885328212440600">Table 2</xref>).
<fig id="fig3-0885328212440600" position="float"><label>Figure 3.</label><caption><p>Proliferation of MC3T3-E1 osteoblasts cultured on smooth or porous CoCrMo and TiN as well as polystyrene after 1, 2, 4, and 7 days. (A) Porous-coated CoCrMo and TiN and (B) smooth CoCrMo, smooth TiN, and polystyrene. CoCrMo: cobalt–chromium–molybdenum and TiN: titanium–nitride. Data are presented as mean ± SEM. *Significantly different from CoCrMo, <italic>p</italic> &lt; 0.05. <sup>#</sup>Significantly different from TiN, <italic>p</italic> &lt; 0.05. <sup>§</sup>Difference approaching significance from CoCrMo, <italic>p</italic> &lt; 0.07.</p></caption><graphic xlink:href="10.1177_0885328212440600-fig3.tif"/>
</fig>
<table-wrap id="table2-0885328212440600" position="float"><label>Table 2.</label><caption><p>Proliferation, differentiation, and IL-6 production of MC3T3-E1 osteoblasts cultured on porous CoCrMo and TiN for 1, 2, 4, or 7 days.</p></caption>
<graphic alternate-form-of="table2-0885328212440600" xlink:href="10.1177_0885328212440600-table2.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="3">Day</th>
<th colspan="9">Porous</th>
</tr>
<tr><th colspan="2">DNA (×10<sup>3 </sup>ng/mL)</th>
<th rowspan="2"><italic>p</italic></th>
<th colspan="2">ALP (nmol/µg)</th>
<th rowspan="2"><italic>p</italic></th>
<th colspan="2">IL-6 (pg/mL)</th>
<th rowspan="2"><italic>p</italic></th>
</tr>
<tr><th>CoCrMo</th>
<th>TiN</th>
<th>CoCrMo</th>
<th>TiN</th>
<th>CoCrMo</th>
<th>TiN</th>
</tr></thead>
<tbody align="left">
<tr>
<td>1</td>
<td>1.29 (0.09)</td>
<td>1.11 (0.10)</td>
<td>0.31</td>
<td>0.21 (0.03)</td>
<td>0.20 (0.03)</td>
<td>0.40</td>
<td>100.1 (19.7)</td>
<td>39.1 (8.7)</td>
<td>0.04</td>
</tr>
<tr>
<td>2</td>
<td>1.63 (0.25)</td>
<td>2.74 (0.08)</td>
<td>&lt;0.01</td>
<td>0.28 (0.02)</td>
<td>0.24 (0.02)</td>
<td>&lt;0.01</td>
<td>74.1 (16.4)</td>
<td>31.9 (5.3)</td>
<td>0.03</td>
</tr>
<tr>
<td>4</td>
<td>1.97 (0.23)</td>
<td>2.63 (0.42)</td>
<td>0.07</td>
<td>0.23 (0.02)</td>
<td>0.20 (0.01)</td>
<td>0.16</td>
<td>74.1 (10.8)</td>
<td>18.5 (5.1)</td>
<td>&lt;0.01</td>
</tr>
<tr>
<td>7</td>
<td>1.45 (0.27)</td>
<td>3.19 (0.37)</td>
<td>&lt;0.01</td>
<td>0.17 (0.03)</td>
<td>0.13 (0.02)</td>
<td>0.04</td>
<td>129.0 (31.7)</td>
<td>30.2 (13.3)</td>
<td>0.01</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn3-0885328212440600">
<p>CoCrMo: cobalt–chromium–molybdenum; TiN: titanium–nitride; ALP: alkaline phosphatase; and IL-6: interleukin-6.</p></fn>
<fn id="table-fn4-0885328212440600">
<p>Data are presented as mean ± SEM.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>Proliferation increased on both smooth CoCrMo (<italic>p</italic> = 0.03) and TiN (<italic>p</italic> = 0.005) from day 1 to 2. Proliferation from day 1 to 7 was 1.6–2.0-fold higher on smooth TiN than that on smooth CoCrMo. Proliferation was similar on smooth TiN and polystyrene from day 1 to 4 (<xref ref-type="fig" rid="fig3-0885328212440600">Figure 3(B)</xref>, <xref ref-type="table" rid="table3-0885328212440600">Table 3</xref>).
<table-wrap id="table3-0885328212440600" position="float"><label>Table 3.</label><caption><p>Proliferation, differentiation, and IL-6 production of MC3T3-E1 osteoblasts cultured on smooth CoCrMo and TiN for 1, 2, 4, or 7 days.</p></caption>
<graphic alternate-form-of="table3-0885328212440600" xlink:href="10.1177_0885328212440600-table3.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="3">Day</th>
<th colspan="9">Smooth</th>
</tr>
<tr><th colspan="2">DNA (×10<sup>3 </sup>ng/mL)</th>
<th rowspan="2"><italic>p</italic></th>
<th colspan="2">ALP (nmol/µg)</th>
<th rowspan="2"><italic>p</italic></th>
<th colspan="2">IL-6 (pg/mL)</th>
<th rowspan="2"><italic>p</italic></th>
</tr>
<tr><th>CoCrMo</th>
<th>TiN</th>
<th>CoCrMo</th>
<th>TiN</th>
<th>CoCrMo</th>
<th>TiN</th>
</tr></thead>
<tbody align="left">
<tr>
<td>1</td>
<td>1.22 (0.08)</td>
<td>2.12 (0.37)</td>
<td>0.04</td>
<td>0.32 (0.06)</td>
<td>0.35 (0.08)</td>
<td>0.60</td>
<td>189.9 (23.3)</td>
<td>156.0 (32.0)</td>
<td>0.37</td>
</tr>
<tr>
<td>2</td>
<td>2.21 (0.36)</td>
<td>3.70 (0.14)</td>
<td>&lt;0.01</td>
<td>0.38 (0.02)</td>
<td>0.40 (0.02)</td>
<td>0.46</td>
<td>143.1 (11.3)</td>
<td>208.0 (7.9)</td>
<td>&lt;0.01</td>
</tr>
<tr>
<td>4</td>
<td>1.89 (0.45)</td>
<td>3.04 (0.35)</td>
<td>0.04</td>
<td>0.33 (0.03)</td>
<td>0.40 (0.03)</td>
<td>0.03</td>
<td>83.7 (13.5)</td>
<td>154.5 (30.3)</td>
<td>0.04</td>
</tr>
<tr>
<td>7</td>
<td>1.81 (0.41)</td>
<td>3.62 (0.17)</td>
<td>&lt;0.01</td>
<td>0.30 (0.04)</td>
<td>0.23 (0.05)</td>
<td>0.03</td>
<td>175.3 (19.3)</td>
<td>151.0 (39.5)</td>
<td>0.50</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn5-0885328212440600">
<p>CoCrMo: cobalt–chromium–molybdenum; TiN: titanium–nitride; ALP: alkaline phosphatase; and IL-6: interleukin-6.</p></fn>
<fn id="table-fn6-0885328212440600">
<p>Data are presented as mean ± SEM.</p></fn></table-wrap-foot>
</table-wrap></p>
</sec>
<sec id="sec12-0885328212440600"><title>Differentiation</title>
<p>On porous CoCrMo, MC3T3-E1 osteoblasts showed increased ALP activity from day 1 to 2 (<italic>p</italic> = 0.04), which decreased thereafter (<italic>p</italic> = 0.002). On porous TiN, there was no change in ALP activity from day 1 to 2, but it decreased by 1.8-fold from day 2 to 7 (<italic>p</italic> &lt; 0.001). MC3T3-E1 osteoblasts on porous TiN showed lower ALP activity on day 4 (<italic>p</italic> &lt; 0.01) and 7 (<italic>p</italic> = 0.04) compared with porous CoCrMo (<xref ref-type="fig" rid="fig4-0885328212440600">Figure 4(A)</xref>, <xref ref-type="table" rid="table2-0885328212440600">Table 2</xref>).
<fig id="fig4-0885328212440600" position="float"><label>Figure 4.</label><caption><p>ALP activity in MC3T3-E1 osteoblasts cultured on smooth or porous CoCrMo or TiN as well as polystyrene after 1, 2, 4, and 7 days. (A) Porous-coated CoCrMo and TiN and (B) smooth CoCrMo, smooth TiN, and polystyrene. CoCrMo: cobalt–chromium–molybdenum and TiN: titanium–nitride. Data are presented as mean ± SEM. *Significantly different from CoCrMo, <italic>p</italic> &lt; 0.05. <sup>#</sup>Significantly different from TiN, <italic>p</italic> &lt; 0.05. <sup>¥</sup>Difference approaching significance from TiN, <italic>p</italic> &lt; 0.06.</p></caption><graphic xlink:href="10.1177_0885328212440600-fig4.tif"/>
</fig></p>
<p>On smooth CoCrMo, MC3T3-E1 osteoblasts showed constant ALP activity levels on day 1 to 7, while on smooth TiN, ALP activity remained constant on day 1 to 4, but decreased thereafter by 1.8-fold on day 7 (<italic>p</italic> = 0.04). Only on day 4, MC3T3-E1 osteoblasts on TiN showed higher ALP activity compared with CoCrMo (<xref ref-type="fig" rid="fig4-0885328212440600">Figure 4(B)</xref>, <xref ref-type="table" rid="table3-0885328212440600">Table 3</xref>).</p>
<p>MC3T3-E1 osteoblasts showed higher ALP activity on smooth CoCrMo on day 1 to 7 and on smooth TiN on day 1 to 4 (<italic>p</italic> &lt; 0.02) as compared with polystyrene. On day 7, ALP activity was marginally higher on smooth TiN compared with polystyrene (<italic>p</italic> = 0.06) (<xref ref-type="fig" rid="fig4-0885328212440600">Figure 4(B)</xref>).</p>
<p>Both porous and smooth CoCrMo and TiN showed an increase in ALP activity on day 1 to 2 which decreased thereafter, except for smooth TiN where ALP activity decreased after day 4 (<xref ref-type="fig" rid="fig4-0885328212440600">Figure 4</xref>).</p>
</sec>
<sec id="sec13-0885328212440600"><title>Cytokine production</title>
<p>On smooth CoCrMo and TiN, the cytokine IL-1β was detected in medium of three out of four cultures on day 1. From day 2 to 7, IL-1β was detected in medium of one out of four cultures on smooth CoCrMo on day 4 and on smooth TiN on day 2 (<xref ref-type="table" rid="table4-0885328212440600">Table 4</xref>). IL-1β was only detected in one out of four cultures on polystyrene on day 2 (<xref ref-type="table" rid="table4-0885328212440600">Table 4</xref>). TNF-α was not detected in any culture.
<table-wrap id="table4-0885328212440600" position="float"><label>Table 4.</label><caption><p>Cytokine IL-1β production by MC3T3-E1 osteoblasts cultured on porous and smooth CoCrMo and TiN surfaces and polystyrene for 1, 2, 4, or 7 days.</p></caption>
<graphic alternate-form-of="table4-0885328212440600" xlink:href="10.1177_0885328212440600-table4.tif"/>
<table frame="hsides"><thead align="left">
<tr><th rowspan="3">Day</th>
<th colspan="20">IL-1β (pg/mL)</th>
</tr>
<tr><th colspan="8">CoCrMo</th>
<th colspan="8">TiN</th>
<th colspan="4">Polystyrene</th>
</tr>
<tr><th colspan="4">smooth</th>
<th colspan="4">porous</th>
<th colspan="4">smooth</th>
<th colspan="4">Porous</th>
<th colspan="4"/>
</tr></thead>
<tbody align="left">
<tr>
<td>1</td>
<td>3.1</td>
<td>–</td>
<td>2.0</td>
<td>1.1</td>
<td>–</td>
<td>–</td>
<td>2.4</td>
<td>3.4</td>
<td>1.6</td>
<td>–</td>
<td>7.6</td>
<td>4.8</td>
<td>2.0</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
<tr>
<td>2</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>6.8</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>0.3</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>3.4</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
<tr>
<td>4</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>4.6</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
<tr>
<td>7</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>1.2</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>2.7</td>
<td>–</td>
<td>1.2</td>
<td>–</td>
<td>–</td>
<td>–</td>
<td>–</td>
</tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="table-fn7-0885328212440600">
<p>CoCrMo: cobalt–chromium–molybdenum; TiN: titanium–nitride; and IL-1β: interleukin-1β.</p></fn></table-wrap-foot>
</table-wrap></p>
<p>On porous CoCrMo, IL-1β was detected in medium of two out of four cultures on day 1 and in one out of four cultures on day 7 (<xref ref-type="table" rid="table4-0885328212440600">Table 4</xref>). On porous TiN, the cytokine IL-1β was detected in medium of one out of four cultures on day 1 and 2, and in two out of four cultures on day 7 (<xref ref-type="table" rid="table4-0885328212440600">Table 4</xref>).</p>
<p>IL-6 production by MC3T3-E1 osteoblasts cultured on porous CoCrMo and TiN remained constant from day 1 to 7, but was higher on porous CoCrMo compared with porous TiN (<italic>p</italic> &lt; 0.05) (<xref ref-type="fig" rid="fig5-0885328212440600">Figure 5(A)</xref>, <xref ref-type="table" rid="table2-0885328212440600">Table 2</xref>).
<fig id="fig5-0885328212440600" position="float"><label>Figure 5.</label><caption><p>IL-6 production by MC3T3-E1 osteoblasts cultured on smooth or porous CoCrMo and TiN as well as polystyrene after 1, 2, 4, and 7 days. (A) porous-coated CoCrMo and TiN and (B) smooth CoCrMo, smooth TiN, and polystyrene. IL-6: interleukin-6; CoCrMo: cobalt–chromium–molybdenum; and TiN: titanium–nitride. Data are presented as mean ± SEM. *Significantly different from CoCrMo, <italic>p</italic> &lt; 0.05. <sup>#</sup>Significantly different from TiN, <italic>p</italic> &lt; 0.05.</p></caption><graphic xlink:href="10.1177_0885328212440600-fig5.tif"/>
</fig></p>
<p>IL-6 production by MC3T3-E1 osteoblasts on smooth CoCrMo first decreased from day 1 to 4 (<italic>p</italic> = 0.01), but increased thereafter (<italic>p</italic> = 0.02). MC3T3-E1 osteoblasts on smooth TiN showed constant IL-6 production from day 1 to 7. IL-6 production on smooth TiN was higher than that on smooth CoCrMo on day 2 (<italic>p</italic> &lt; 0.01) and day 4 (<italic>p</italic> = 0.04) (<xref ref-type="fig" rid="fig5-0885328212440600">Figure 5(B)</xref>, <xref ref-type="table" rid="table3-0885328212440600">Table 3</xref>). IL-6 production by osteoblasts expressed per amount of DNA did not show a difference between smooth TiN and CoCrMo (data not shown). Compared with polystyrene, IL-6 production was lower on day 1 to 7 by cells grown on smooth CoCrMo and TiN (<italic>p</italic> &lt; 0.001) (<xref ref-type="fig" rid="fig5-0885328212440600">Figure 5(B)</xref>).</p>
<p>In summary, higher MC3T3-E1 osteoblast proliferation on day 2 and 7, lower differentiation on day 2 and 7, and lower IL-6 production were found on porous TiN compared with porous CoCrMo (<xref ref-type="table" rid="table2-0885328212440600">Table 2</xref>). On smooth surfaces, higher proliferation, similar differentiation, and similar IL-6 production by MC3T3-E1 osteoblasts on TiN compared with CoCrMo were found (<xref ref-type="table" rid="table3-0885328212440600">Table 3</xref>). Increased proliferation, differentiation, and IL-6 production were found on smooth surfaces compared with porous surfaces.</p>
</sec>
</sec>
<sec id="sec14-0885328212440600" sec-type="discussion"><title>Discussion</title>
<p>Total knee arthroplasty can relieve pain and disability resulting from severe osteoarthritis of the knee with a high rate of success.<sup><xref ref-type="bibr" rid="bibr1-0885328212440600">1</xref>,<xref ref-type="bibr" rid="bibr2-0885328212440600">2</xref></sup> Questions have been raised about the long-term durability of cemented fixation in younger patients, leading to the design of uncemented total knee arthroplasty to improve implant longevity.<sup><xref ref-type="bibr" rid="bibr7-0885328212440600">7</xref>,<xref ref-type="bibr" rid="bibr8-0885328212440600">8</xref></sup> The uncemented prosthesis fixates to bone by osteoconduction and osseointegration resulting in bone ingrowth into the porous implant surface, thereby providing a solid implant fixation.<sup><xref ref-type="bibr" rid="bibr6-0885328212440600">6</xref></sup> However, uncemented total knee arthroplasty shows higher rates of early failure than cemented total knee arthroplasty due to aseptic loosening.<sup><xref ref-type="bibr" rid="bibr4-0885328212440600">4</xref>,<xref ref-type="bibr" rid="bibr5-0885328212440600">5</xref></sup> In an <italic>in vitro</italic> mouse model for aseptic loosening, cytokines IL-1β, IL-6, and TNF-α induce osteoclast differentiation.<sup><xref ref-type="bibr" rid="bibr22-0885328212440600">22</xref></sup> Additionally, chromium and cobalt ions have been shown to diminish osteoblast growth and metabolism.<sup><xref ref-type="bibr" rid="bibr12-0885328212440600">12</xref><xref ref-type="bibr" rid="bibr13-0885328212440600"/>–<xref ref-type="bibr" rid="bibr14-0885328212440600">14</xref></sup> Sometimes implants are coated with a TiN layer to enhance implant hardness and wear resistance and lower the friction coefficient of the articular surface, in order to improve long-term implant survival.<sup><xref ref-type="bibr" rid="bibr10-0885328212440600">10</xref></sup> Whether TiN also affects osteoconduction by osteoblasts is unknown. We hypothesized that MC3T3-E1 osteoblasts on porous or smooth TiN surface show increased proliferation and differentiation and decreased cytokine production compared with osteoblasts on CoCrMo surface.</p>
<p>This study reveals that cultured MC3T3-E1 osteoblasts show increased proliferation on both porous and smooth TiN compared with CoCrMo. Furthermore, osteoblast proliferation on smooth TiN was similar to that on polystyrene, suggesting favorable properties of TiN over CoCrMo with regard to cell proliferation. Osteoblast proliferation did not rise exponentially from day 4 to 7, which is unexpected given the rise in proliferation from day 1 to 2 and the lack of a rise in differentiation in all groups. It is likely that MC3T3-E1 osteoblasts reached confluency on smooth surfaces which inhibits further proliferation.</p>
<p>Differentiation of MC3T3-E1 osteoblasts cultured on porous TiN, as indicated by ALP activity, was lower compared with porous CoCrMo. ALP activity was decreased on both types of surfaces on day 2 to 7. Cultured MC3T3-E1 osteoblasts in the growing state are known to have very low ALP enzyme activity, but ALP enzyme activity increases after cells reach confluency.<sup><xref ref-type="bibr" rid="bibr25-0885328212440600">25</xref></sup> In addition, ALP activity increases significantly with the onset of growth arrest of MC3T3-E1 osteoblasts.<sup><xref ref-type="bibr" rid="bibr26-0885328212440600">26</xref></sup> On porous surfaces, MC3T3-E1 osteoblasts likely did not reach growth arrest, which could explain the low ALP activity of these cells on both porous surfaces. Compared with polystyrene, MC3T3-E1 osteoblasts cultured on smooth TiN and CoCrMo showed higher ALP activity, suggesting increased MC3T3-E1 osteoblast differentiation on these implant surfaces.</p>
<p>In bone, the cytokine IL-6 is mainly produced by osteoblasts and stromal cells.<sup><xref ref-type="bibr" rid="bibr27-0885328212440600">27</xref></sup> IL-6 stimulates osteoclast differentiation in a synergistic fashion with TNF-α and IL-1β, which results in a net increase of RANKL activity, leading to stimulation of osteoclast precursor differentiation in mature osteoclasts.<sup><xref ref-type="bibr" rid="bibr20-0885328212440600">20</xref>,<xref ref-type="bibr" rid="bibr22-0885328212440600">22</xref></sup> We found that IL-6 production by MC3T3-E1 osteoblasts was lower on porous TiN than that on porous CoCrMo, which might suggest an inhibitory effect of TiN on osteoclastogenesis or an absence of stimulation of osteoclastogenesis by TiN. The cytokines IL-1, IL-6, and TNF-α synergistically stimulate osteoclast differentiation <italic>in vitro</italic>, although genetic knock out of these cytokines does not alter osteolysis in mice.<sup><xref ref-type="bibr" rid="bibr22-0885328212440600">22</xref></sup> Therefore, the differences found in ALP activity and cytokine production by MC3T3-E1 osteoblasts cultured on the TiN and CoCrMo surfaces might not be physiologically relevant and caution is needed when extrapolating our conclusions to the <italic>in vivo</italic> situation.</p>
<p>IL-6 production was higher on smooth TiN compared with smooth CoCrMo at day 2 and 4, which contradicts the lower IL-6 production on porous TiN compared with CoCrMo. IL-6 production was expressed in pg/ng DNA per disc to correct for possible influences of differences in cell number on IL-6 production. IL-6 production, expressed in pg/mL culture medium as well as in pg/ng DNA, was lower on porous TiN compared with porous CoCrMo. In contrast, IL-6 production expressed in pg/mL culture medium, but not in pg/ng DNA, was higher on day 2 and 4 on smooth TiN compared with smooth CoCrMo.</p>
<p>Recently, it has been proposed that IL-6 and IL-6-type cytokines have a dual role, i.e. besides their stimulatory effect on bone resorption, they also exert a positive effect on bone formation.<sup><xref ref-type="bibr" rid="bibr28-0885328212440600">28</xref>,<xref ref-type="bibr" rid="bibr29-0885328212440600">29</xref></sup> The stimulatory effect of IL-6-type cytokines on bone formation has been suggested to depend on the differentiation stage of osteoblasts.<sup><xref ref-type="bibr" rid="bibr30-0885328212440600">30</xref></sup> IL-6-type cytokines would stimulate the early stages of osteogenic differentiation of precursor cells, but prevent further stimulation of more mature cells.<sup><xref ref-type="bibr" rid="bibr30-0885328212440600">30</xref></sup> Since MC3T3-E1 osteoblasts are rather mature cells, high IL-6 levels would prevent these cells from further proliferation and differentiation.</p>
<p>The cytokines TNF-α and IL-1β play an important role in osteoclastogenesis in a synergistic fashion with IL-6.<sup><xref ref-type="bibr" rid="bibr20-0885328212440600">20</xref></sup> In addition, cytokines TNF-α and IL-1β are upregulated in aseptic loosening <italic>in vivo</italic>.<sup><xref ref-type="bibr" rid="bibr31-0885328212440600">31</xref><xref ref-type="bibr" rid="bibr32-0885328212440600"/>–<xref ref-type="bibr" rid="bibr33-0885328212440600">33</xref></sup> IL-1β was only detected in medium of a few MC3T3-E1 osteoblast cultures on porous and smooth CoCrMo and TiN surfaces, while TNF-α was not detected, indicating that IL-1β and TNF-α production by osteoblasts on these surfaces is limited and unlikely to lead to dramatic changes in osteoclastic bone resorption.</p>
<p>SEM showed differences between the smooth CoCrMo discs (DePuy-Johnson and Johnson) and smooth TiN discs (Implantcast) provided by the two manufacturers. The smooth CoCrMo surface was metallurgically polished, whereas the smooth TiN surface showed a circular pattern with approximately 100 µm distance between the tracks. On day 2 and 4, the MC3T3-E1 osteoblasts aligned the circular pattern of the smooth TiN surface. Topographic features with dimensions approximating the cell size have been reported to have strong effects on cell guidance and shape regulation.<sup><xref ref-type="bibr" rid="bibr34-0885328212440600">34</xref></sup> A comparative study on microgrooved hydroxyapatite and titanium did reveal a difference in shape regulation, but not contact guidance of osteoblast-like cells.<sup><xref ref-type="bibr" rid="bibr34-0885328212440600">34</xref></sup> This suggests that the surface chemistry affects osteoblast behavior.<sup><xref ref-type="bibr" rid="bibr34-0885328212440600">34</xref></sup> Since our SEM images of the porous material surfaces suggest similar topography, and because proliferation, differentiation, and cytokine production were similar to findings on smooth surfaces, we suggest that the observed differences in proliferation, differentiation, and cytokine production on smooth surfaces were due to surface chemistry.</p>
<p>Kubies et al.<sup><xref ref-type="bibr" rid="bibr35-0885328212440600">35</xref></sup> reported on human osteoblast proliferation and the expression of TNF-α and bone ALP amongst other tissue mediators by these cells after culture on commercially available implant materials such as titanium and titanium–aluminum–vanadium alloy with various surface treatments, CoCrMo alloy, zirconium oxide ceramics, stainless steel, polyethylene, and carbon/carbon composite. After 4 days of culture, the number of proliferating cells was determined and polished CoCrMo was amongst the least suitable surfaces for osteoblast culture.<sup><xref ref-type="bibr" rid="bibr35-0885328212440600">35</xref></sup> Our results showed higher proliferation on smooth TiN than that on CoCrMo. This suggests that a TiN coating makes a CoCrMo surface more suitable for osteoblast culture.</p>
<p>We cultured MC3T3-E1 osteoblasts on TiN and CoCrMo surfaces as used in total knee arthroplasty and found differences in proliferation, differentiation, and cytokine production. Bone formation around the implant, is dependent on biophysical stimuli and soft-tissue formation.<sup><xref ref-type="bibr" rid="bibr36-0885328212440600">36</xref></sup> Osteoblasts arrive in a later stage of interface tissue formation,<sup><xref ref-type="bibr" rid="bibr36-0885328212440600">36</xref></sup> but for osseointegration, osteoblast proliferation and differentiation along the implant surface is needed. Therefore, our results on <italic>in vitro</italic> proliferation, differentiation, and cytokine production of osteoblasts on implant surfaces might have implications <italic>in vivo</italic>.</p>
<p>In conclusion, MC3T3-E1 osteoblasts cultured on porous or smooth TiN surfaces showed similar differentiation but increased proliferation compared with CoCrMo surfaces. IL-6 production by osteoblasts on TiN surfaces was decreased on porous surfaces and on smooth surfaces. The clinical implications of these findings might be decreased bone resorption and enhanced osteoconduction leading to improved osseointegration. Further research on osteoconduction and clinical research on osseointegration may reveal a lower risk of early aseptic loosening of TiN-coated implants as compared with CoCrMo implants.</p>
</sec>
</body>
<back><ack><title>Acknowledgments</title>
<p>The authors thank A. Werner for excellent technical support with SEM and D. Holmes for critically reading the manuscript. All authors have no conflict of interest.</p></ack>
<sec id="sec15-0885328212440600"><title>Funding</title>
<p>This study received financial assistance from the Foundation of Orthopaedic Research Spaarne Hospital, Hoofddorp, The Netherlands.</p>
</sec>
<ref-list><title>References</title>
<ref id="bibr1-0885328212440600"><label>1</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gandhi</surname><given-names>R</given-names></name><name><surname>Tsvetkov</surname><given-names>D</given-names></name><name><surname>Davey</surname><given-names>JR</given-names></name><etal/></person-group>. <article-title>Survival and clinical function of cemented and uncemented prostheses in total knee replacement: a meta-analysis</article-title>. <source>J Bone Joint Surg (Br)</source> <year>2009</year>; <volume>91</volume>: <fpage>889</fpage>–<lpage>895</lpage>.</citation></ref>
<ref id="bibr2-0885328212440600"><label>2</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Norman-Taylor</surname><given-names>FH</given-names></name><name><surname>Palmer</surname><given-names>CR</given-names></name><name><surname>Villar</surname><given-names>RN</given-names></name></person-group>. <article-title>Quality-of-life improvement compared after hip and knee replacement</article-title>. <source>J Bone Joint Surg (Br)</source> <year>1996</year>; <volume>78–B</volume>: <fpage>74</fpage>–<lpage>77</lpage>.</citation></ref>
<ref id="bibr3-0885328212440600"><label>3</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barrack</surname><given-names>RL</given-names></name><name><surname>Nakamura</surname><given-names>SJ</given-names></name><name><surname>Hopkins</surname><given-names>SG</given-names></name><etal/></person-group>. <article-title>Early failure of cementless mobile-bearing total knee arthroplasty</article-title>. <source>J Arthroplasty</source> <year>2004</year>; <volume>19</volume>: <fpage>101</fpage>–<lpage>106</lpage>.</citation></ref>
<ref id="bibr4-0885328212440600"><label>4</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fehring</surname><given-names>TK</given-names></name><name><surname>Odum</surname><given-names>S</given-names></name><name><surname>Griffin</surname><given-names>WL</given-names></name><etal/></person-group>. <article-title>Early failures in total knee arthroplasty</article-title>. <source>Clin Orthop Relat Res</source> <year>2001</year>; <volume>392</volume>: <fpage>315</fpage>–<lpage>318</lpage>.</citation></ref>
<ref id="bibr5-0885328212440600"><label>5</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sharkey</surname><given-names>PF</given-names></name><name><surname>Hozack</surname><given-names>WJ</given-names></name><name><surname>Rothman</surname><given-names>RH</given-names></name><etal/></person-group>. <article-title>Why are total knee arthroplasties failing today?</article-title>. <source>Clin Orthop Relat Res</source> <year>2002</year>; <volume>404</volume>: <fpage>7</fpage>–<lpage>13</lpage>.</citation></ref>
<ref id="bibr6-0885328212440600"><label>6</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albrektsson</surname><given-names>T</given-names></name><name><surname>Johansson</surname><given-names>C</given-names></name></person-group>. <article-title>Osteoinduction, osteoconduction and osseointegration</article-title>. <source>Eur Spine J</source> <year>2001</year>; <volume>10</volume>: <fpage>S96</fpage>–<lpage>S101</lpage>.</citation></ref>
<ref id="bibr7-0885328212440600"><label>7</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Naudie</surname><given-names>DD</given-names></name><name><surname>Ammeen</surname><given-names>DJ</given-names></name><name><surname>Engh</surname><given-names>GA</given-names></name><etal/></person-group>. <article-title>Wear and osteolysis around total knee arthroplasty</article-title>. <source>J Am Acad Orthop Surg</source> <year>2007</year>; <volume>15</volume>: <fpage>53</fpage>–<lpage>64</lpage>.</citation></ref>
<ref id="bibr8-0885328212440600"><label>8</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bassett</surname><given-names>RW</given-names></name></person-group>. <article-title>Results of 1000 performance knees: cementless versus cemented fixation</article-title>. <source>J Arthroplasty</source> <year>1998</year>; <volume>13</volume>: <fpage>409</fpage>–<lpage>413</lpage>.</citation></ref>
<ref id="bibr9-0885328212440600"><label>9</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Marti</surname><given-names>A</given-names></name></person-group>. <article-title>Cobalt-base alloys used in bone surgery</article-title>. <source>Injury</source> <year>2000</year>; <volume>31</volume>(<issue>Suppl. 4</issue>): <fpage>18</fpage>–<lpage>21</lpage>.</citation></ref>
<ref id="bibr10-0885328212440600"><label>10</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wisbey</surname><given-names>A</given-names></name><name><surname>Gregson</surname><given-names>PJ</given-names></name><name><surname>Tuke</surname><given-names>M</given-names></name></person-group>. <article-title>Application of PVD TiN coating to Co-Cr-Mo based surgical implants</article-title>. <source>Biomaterials</source> <year>1987</year>; <volume>8</volume>: <fpage>477</fpage>–<lpage>480</lpage>.</citation></ref>
<ref id="bibr11-0885328212440600"><label>11</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mezger</surname><given-names>PR</given-names></name><name><surname>Creugers</surname><given-names>NHJ</given-names></name></person-group>. <article-title>Titanium nitride coatings in clinical dentistry</article-title>. <source>J Dent</source> <year>1992</year>; <volume>20</volume>: <fpage>342</fpage>–<lpage>344</lpage>.</citation></ref>
<ref id="bibr12-0885328212440600"><label>12</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Allen</surname><given-names>MJ</given-names></name><name><surname>Myer</surname><given-names>BJ</given-names></name><name><surname>Millett</surname><given-names>PJ</given-names></name><etal/></person-group>. <article-title>The effects of particulate cobalt, chromium and cobalt-chromium alloy on human osteoblast-like cells in vitro</article-title>. <source>J Bone Joint Surg (Br)</source> <year>1997</year>; <volume>79</volume>: <fpage>475</fpage>–<lpage>482</lpage>.</citation></ref>
<ref id="bibr13-0885328212440600"><label>13</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fleury</surname><given-names>C</given-names></name><name><surname>Petit</surname><given-names>A</given-names></name><name><surname>Mwale</surname><given-names>F</given-names></name><etal/></person-group>. <article-title>Effect of cobalt and chromium ions on human MG-63 osteoblasts in vitro: morphology, cytotoxicity, and oxidative stress</article-title>. <source>Biomaterials</source> <year>2006</year>; <volume>27</volume>: <fpage>3351</fpage>–<lpage>3360</lpage>.</citation></ref>
<ref id="bibr14-0885328212440600"><label>14</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wang</surname><given-names>JY</given-names></name><name><surname>Wicklund</surname><given-names>BH</given-names></name><name><surname>Gustilo</surname><given-names>RB</given-names></name><etal/></person-group>. <article-title>Prosthetic metals interfere with the functions of human osteoblast cells in vitro</article-title>. <source>Clin Orthop Relat Res</source> <year>1997</year>; <volume>339</volume>: <fpage>216</fpage>–<lpage>226</lpage>.</citation></ref>
<ref id="bibr15-0885328212440600"><label>15</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bilbe</surname><given-names>G</given-names></name><name><surname>Roberts</surname><given-names>E</given-names></name><name><surname>Birch</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>PCR Phenotyping of cytokines, growth factors and their receptors and bone matrix proteins in human osteoblast-like cell lines</article-title>. <source>Bone</source> <year>1996</year>; <volume>19</volume>: <fpage>437</fpage>–<lpage>445</lpage>.</citation></ref>
<ref id="bibr16-0885328212440600"><label>16</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Gowen</surname><given-names>M</given-names></name><name><surname>Chapman</surname><given-names>K</given-names></name><name><surname>Littlewood</surname><given-names>A</given-names></name><etal/></person-group>. <article-title>Production of tumor necrosis factor by human osteoblasts is modulated by other cytokines, but not by osteotropic hormones</article-title>. <source>Endocrinology</source> <year>1990</year>; <volume>126</volume>: <fpage>1250</fpage>–<lpage>1255</lpage>.</citation></ref>
<ref id="bibr17-0885328212440600"><label>17</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hanazawa</surname><given-names>S</given-names></name><name><surname>Ohmori</surname><given-names>Y</given-names></name><name><surname>Amano</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>Spontaneous production of interleukin-1-like cytokine from a mouse osteoblastic cell line (MC3T3-E1)</article-title>. <source>Biochem Biophys Res Commun</source> <year>1985</year>; <volume>131</volume>: <fpage>774</fpage>–<lpage>779</lpage>.</citation></ref>
<ref id="bibr18-0885328212440600"><label>18</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ishimi</surname><given-names>Y</given-names></name><name><surname>Miyaura</surname><given-names>C</given-names></name><name><surname>Jin</surname><given-names>CH</given-names></name><etal/></person-group>. <article-title>IL-6 is produced by osteoblasts and induces bone resorption</article-title>. <source>J Immun</source> <year>1990</year>; <volume>145</volume>: <fpage>3297</fpage>–<lpage>3303</lpage>.</citation></ref>
<ref id="bibr19-0885328212440600"><label>19</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Passeri</surname><given-names>G</given-names></name><name><surname>Girasole</surname><given-names>G</given-names></name><name><surname>Manolagas</surname><given-names>SC</given-names></name><etal/></person-group>. <article-title>Endogenous production of tumor necrosis factor by primary cultures of murine calvarial cells: influence on IL-6 production and osteoclast development</article-title>. <source>Bone Miner</source> <year>1994</year>; <volume>24</volume>: <fpage>109</fpage>–<lpage>126</lpage>.</citation></ref>
<ref id="bibr20-0885328212440600"><label>20</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kwan Tat</surname><given-names>S</given-names></name><name><surname>Padrines</surname><given-names>M</given-names></name><name><surname>Théoleyre</surname><given-names>S</given-names></name><etal/></person-group>. <article-title>IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology</article-title>. <source>Cytokine Growth Factor Rev</source> <year>2004</year>; <volume>15</volume>: <fpage>49</fpage>–<lpage>60</lpage>.</citation></ref>
<ref id="bibr21-0885328212440600"><label>21</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ragab</surname><given-names>AA</given-names></name><name><surname>Nalepka</surname><given-names>JL</given-names></name><name><surname>Bi</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Cytokines synergistically induce osteoclast differentiation: support by immortalized or normal calvarial cells</article-title>. <source>Am J Physiol Cell Physiol</source> <year>2002</year>; <volume>283</volume>: <fpage>C679</fpage>–<lpage>C687</lpage>.</citation></ref>
<ref id="bibr22-0885328212440600"><label>22</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taki</surname><given-names>N</given-names></name><name><surname>Tatro</surname><given-names>JM</given-names></name><name><surname>Lowe</surname><given-names>R</given-names></name><etal/></person-group>. <article-title>Comparison of the roles of IL-1, IL-6, and TNF-α in cell culture and murine models of aseptic loosening</article-title>. <source>Bone</source> <year>2007</year>; <volume>40</volume>: <fpage>1276</fpage>–<lpage>1283</lpage>.</citation></ref>
<ref id="bibr23-0885328212440600"><label>23</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Mullender</surname><given-names>MG</given-names></name><name><surname>Dijcks</surname><given-names>SJ</given-names></name><name><surname>Bacabac</surname><given-names>RG</given-names></name><etal/></person-group>. <article-title>Release of nitric oxide, but not prostaglandin E2, by bone cells depends on fluid flow frequency</article-title>. <source>J Orthop Res</source> <year>2006</year>; <volume>24</volume>: <fpage>1170</fpage>–<lpage>1177</lpage>.</citation></ref>
<ref id="bibr24-0885328212440600"><label>24</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Bessey</surname><given-names>OA</given-names></name><name><surname>Lowry</surname><given-names>OH</given-names></name><name><surname>Brock</surname><given-names>MJ</given-names></name></person-group>. <article-title>A method for the rapid determination of alkaline phosphatase with five cubic millimeters of serum</article-title>. <source>J Biol Chem</source> <year>1946</year>; <volume>164</volume>: <fpage>331</fpage>–<lpage>339</lpage>.</citation></ref>
<ref id="bibr25-0885328212440600"><label>25</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sudo</surname><given-names>H</given-names></name><name><surname>Kodama</surname><given-names>HA</given-names></name><name><surname>Amagai</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria</article-title>. <source>J Cell Biol</source> <year>1983</year>; <volume>96</volume>: <fpage>191</fpage>–<lpage>198</lpage>.</citation></ref>
<ref id="bibr26-0885328212440600"><label>26</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Quarles</surname><given-names>LD</given-names></name><name><surname>Yohay</surname><given-names>DA</given-names></name><name><surname>Lever</surname><given-names>LW</given-names></name><etal/></person-group>. <article-title>Distinct proliferative and differentiated stages of murine MC3T3-E1 cells in culture: an in vitro model of osteoblast development</article-title>. <source>J Bone Miner Res</source> <year>1992</year>; <volume>6</volume>: <fpage>683</fpage>–<lpage>692</lpage>.</citation></ref>
<ref id="bibr27-0885328212440600"><label>27</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Holt</surname><given-names>I</given-names></name><name><surname>Davie</surname><given-names>WJ</given-names></name><name><surname>Marshall</surname><given-names>MJ</given-names></name></person-group>. <article-title>Osteoclasts are not the major source of interleukin-6 in mouse parietal bones</article-title>. <source>Bone</source> <year>1996</year>; <volume>18</volume>: <fpage>221</fpage>–<lpage>226</lpage>.</citation></ref>
<ref id="bibr28-0885328212440600"><label>28</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Blanchard</surname><given-names>F</given-names></name><name><surname>Duplomb</surname><given-names>L</given-names></name><name><surname>Baud'huin</surname><given-names>M</given-names></name><etal/></person-group>. <article-title>The dual role of IL-6-type cytokines on bone remodeling and bone tumors</article-title>. <source>Cytokine Growth Factor Rev</source> <year>2009</year>; <volume>20</volume>: <fpage>19</fpage>–<lpage>28</lpage>.</citation></ref>
<ref id="bibr29-0885328212440600"><label>29</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Franchimont</surname><given-names>N</given-names></name><name><surname>Wertz</surname><given-names>S</given-names></name><name><surname>Malaise</surname><given-names>M</given-names></name></person-group>. <article-title>Interleukin-6: an osteotropic factor influencing bone formation?</article-title>. <source>Bone</source> <year>2005</year>; <volume>37</volume>: <fpage>601</fpage>–<lpage>606</lpage>.</citation></ref>
<ref id="bibr30-0885328212440600"><label>30</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Malaval</surname><given-names>L</given-names></name><name><surname>Aubin</surname><given-names>JE</given-names></name></person-group>. <article-title>Biphasic effects of leukemia inhibitory factor on osteoblastic differentiation</article-title>. <source>J Cell Biochem Suppl</source> <year>2001</year>; <volume>36</volume>: <fpage>63</fpage>–<lpage>70</lpage>.</citation></ref>
<ref id="bibr31-0885328212440600"><label>31</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Goodman</surname><given-names>SB</given-names></name><name><surname>Huie</surname><given-names>P</given-names></name><name><surname>Song</surname><given-names>Y</given-names></name><etal/></person-group>. <article-title>Cellular profile and cytokine production at prosthetic interfaces. Study of tissues retrieved from revised hip and knee replacements</article-title>. <source>J Bone Joint Surg (Br)</source> <year>1998</year>; <volume>80</volume>: <fpage>531</fpage>–<lpage>539</lpage>.</citation></ref>
<ref id="bibr32-0885328212440600"><label>32</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hicks</surname><given-names>DG</given-names></name><name><surname>Judkins</surname><given-names>AR</given-names></name><name><surname>Sickel</surname><given-names>JZ</given-names></name><etal/></person-group>. <article-title>Granular histiocytosis of pelvic lymph nodes following total hip arthroplasty. The presence of wear debris, cytokine production, and immunologically activated macrophages</article-title>. <source>J Bone Joint Surg (Am)</source> <year>1996</year>; <volume>78</volume>: <fpage>482</fpage>–<lpage>496</lpage>.</citation></ref>
<ref id="bibr33-0885328212440600"><label>33</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Stea</surname><given-names>S</given-names></name><name><surname>Visentin</surname><given-names>M</given-names></name><name><surname>Granchi</surname><given-names>D</given-names></name><etal/></person-group>. <article-title>Cytokines and osteolysis around total hip prostheses</article-title>. <source>Cytokine</source> <year>2000</year>; <volume>12</volume>: <fpage>1575</fpage>–<lpage>1579</lpage>.</citation></ref>
<ref id="bibr34-0885328212440600"><label>34</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname><given-names>X</given-names></name><name><surname>Leng</surname><given-names>Y</given-names></name></person-group>. <article-title>Quantitative analysis of osteoblast behavior on microgrooved hydroxyapatite and titanium substrata</article-title>. <source>J Biomed Mater Res Part A</source> <year>2003</year>; <volume>66</volume>: <fpage>677</fpage>–<lpage>687</lpage>.</citation></ref>
<ref id="bibr35-0885328212440600"><label>35</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Kubies</surname><given-names>D</given-names></name><name><surname>Himmlová</surname><given-names>L</given-names></name><name><surname>Riedel</surname><given-names>T</given-names></name><etal/></person-group>. <article-title>The interaction of osteoblasts with bone-implant materials: 1. The effect of physicochemical surface properties of implant materials</article-title>. <source>Physiol Res</source> <year>2011</year>; <volume>60</volume>: <fpage>95</fpage>–<lpage>111</lpage>.</citation></ref>
<ref id="bibr36-0885328212440600"><label>36</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Prendergast</surname><given-names>PJ</given-names></name><name><surname>Huiskes</surname><given-names>R</given-names></name><name><surname>Søballe</surname><given-names>K</given-names></name></person-group>. <article-title>Biophysical stimuli on cells during tissue differentiation at implant surfaces</article-title>. <source>J Biomechanics</source> <year>1997</year>; <volume>30</volume>: <fpage>539</fpage>–<lpage>548</lpage>.</citation></ref>
</ref-list>
</back>
</article>